Benitec Biopharma Inc. SEC filings BNTC

Benitec Biopharma Inc. has 334 filings in SEC EDGAR's recent list, going back to Apr 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 14, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.

Benitec Biopharma Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Feb 13, 2023 Dec 31, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report May 12, 2021 Mar 31, 2021
10-Q Quarterly report Feb 9, 2021 Dec 31, 2020
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BNTC (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Hayward, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1808898

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.